EORTC Presentations at ESMO 2016 Congress in Copenhagen
29 Sep 2016
EORTC investigators will present the results of their cancer research at ESMO 2016 Congress, 7 – 11 October 2016 in Copenhagen.
Presidential Symposium
Details: ESMO 2016 Comgress, 08.10.2016, 16:30 – 18:00, Copenhagen
Abstract: 3070
Authors: Alexander MM Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards, Céleste Lebbé, Virginia Ferraresi, Michael Smylie, Jeffrey S Weber, Corina Taitt, Veerle de Pril, Gaetan de Schaetzen, Stefan Suciu, Alessandro Testori
Poster Discussion session
Details: ESMO 2016 Congress, 10.10.2016, 13:00 – 14:00, Hall E
Abstract: 3615
Authors: Nathan Touati, Konstantinos Tryfonidis, Franco Caramia, Hervé Bonnefoi, David Cameron, Leen Slaets, Belinda S Parker, Sherene Loi
Details: ESMO 2016 Congress, 10.10.2016, 13:00 – 14:00, Hall E
Abstract: 2355
Authors: Kollár A, Jones RL, Stacchiotti S, Gelderblom H, Guida M, Boccone P, Steeghs N, Safwat A, Katz D, Duffaud F, Sleijfer S, van der Graaf WT, Touati N, Litière S, Marreaud S, Gronchi A, Kasper B
Details: ESMO 2016 Congress, 10.10.2016, 13:00 – 14:00, Hall E
Authors: Ray-Coquard I, Dei Tos A, Coens C, Huizing MT, Casado A, Westermann AM, Bompas E, Earl H, Hensley ML, Negrouk A, Reed N.
Details: ESMO 2016 Congress, 08.10.2016, 13:00 – 14:00, Hall E
Abstract: 2167
Authors: V. Cristina, J Mahachie, M Mauer, C Csajka, E Van Cutsem, AD Wagner
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023